These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 20384533

  • 1. Renal toxicity associated with tenofovir use.
    Rodriguez-Nóvoa S, Alvarez E, Labarga P, Soriano V.
    Expert Opin Drug Saf; 2010 Jul; 9(4):545-59. PubMed ID: 20384533
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy.
    Côté HC, Magil AB, Harris M, Scarth BJ, Gadawski I, Wang N, Yu E, Yip B, Zalunardo N, Werb R, Hogg R, Harrigan PR, Montaner JS.
    Antivir Ther; 2006 Jul; 11(1):79-86. PubMed ID: 16518963
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of tenofovir on renal glomerular and tubular function.
    Fux CA, Christen A, Zgraggen S, Mohaupt MG, Furrer H.
    AIDS; 2007 Jul 11; 21(11):1483-5. PubMed ID: 17589197
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antiretroviral medications: adverse effects on the kidney.
    Jao J, Wyatt CM.
    Adv Chronic Kidney Dis; 2010 Jan 11; 17(1):72-82. PubMed ID: 20005491
    [Abstract] [Full Text] [Related]

  • 10. [Acute renal failure and proximal renal tubular dysfuntion in a patient with acquired immunodeficiency syndrome treated with tenofovir].
    de la Prada FJ, Prados AM, Tugores A, Uriol M, Saus C, Morey A.
    Nefrologia; 2006 Jan 11; 26(5):626-30. PubMed ID: 17117909
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Editorial comment: tenofovir-related nephrotoxicity--who's at risk?
    Gupta Samir K.
    AIDS Read; 2007 Feb 11; 17(2):102-3. PubMed ID: 17323509
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Renal function in antiretroviral-experienced patients treated with tenofovir disoproxil fumarate associated with atazanavir/ritonavir.
    Gérard L, Chazallon C, Taburet AM, Girard PM, Aboulker JP, Piketty C.
    Antivir Ther; 2007 Feb 11; 12(1):31-9. PubMed ID: 17503745
    [Abstract] [Full Text] [Related]

  • 15. Proximal tubular dysfunction associated with tenofovir and didanosine causing Fanconi syndrome and diabetes insipidus: a report of 3 cases.
    Irizarry-Alvarado JM, Dwyer JP, Brumble LM, Alvarez S, Mendez JC.
    AIDS Read; 2009 Mar 11; 19(3):114-21. PubMed ID: 19334328
    [Abstract] [Full Text] [Related]

  • 16. Tenofovir-induced nephrotoxicity: myths and facts.
    Gupta A, Bugeja A, Kirpalani D.
    Saudi J Kidney Dis Transpl; 2012 Jan 11; 23(1):148-9. PubMed ID: 22237241
    [No Abstract] [Full Text] [Related]

  • 17. Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir.
    Crane HM, Kestenbaum B, Harrington RD, Kitahata MM.
    AIDS; 2007 Jul 11; 21(11):1431-9. PubMed ID: 17589189
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy.
    Parsonage MJ, Wilkins EG, Snowden N, Issa BG, Savage MW.
    HIV Med; 2005 Sep 11; 6(5):341-6. PubMed ID: 16156882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.